Qing‐Kun Shen

Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway

Qing‐Kun Shen, Hao Deng, Shi-Ben Wang et al. · European Journal of Medicinal Chemistry · 2019 · 66 citations

Vivo Anticancer Activity, Medicine, P53-mdm2 Pathway +8

Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents

Haibin Zhang, Qing‐Kun Shen, Hui Wang et al. · European Journal of Medicinal Chemistry · 2018 · 41 citations

Engineering, Antiparasitic Agent, Medicine +6

Structurally modified glycyrrhetinic acid derivatives as anti-inflammatory agents

Ming Bian, Zhen Dong, Qing‐Kun Shen et al. · Bioorganic Chemistry · 2020 · 41 citations

Anti-inflammatory, Glycyrrhetinic Acid Derivatives, Medicine +4

Arctigenin: pharmacology, total synthesis, and progress in structure modification

Dan Wu, Lili Jin, Xing Huang et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 32 citations · Full text

Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one–linked to triazole moieties as potent cytotoxic agents

Chuanfeng Liu, Qing‐Kun Shen, Jiajun Li et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 31 citations · Full text